demonstrate a greener borrowinghydrogen methodology using the π-benzylpalladium system, which offers an efficient and environmentally friendly dehydrative N-monobenzylation of 2-aminopyridines with benzylic alcohols in the absence of base. The crossover experiment using benzyl-α,α-d2 alcohol and 3-methylbenzyl alcohol afforded H/D scrambled products, suggesting that the dehydrative N-benzylation in our
我们证明了使用π-苄基钯体系的更绿色的借用氢方法,该方法可在不存在碱的情况下,用苄基醇对2-氨基吡啶进行高效,环保的N-单苄基脱水。使用苄基-α交叉的实验中,α- d 2醇和3-甲基苄基,得到H / d醇加扰的产品,这表明脱水Ñ在我们的催化系统中,苄基化涉及一个借用的氢途径。KIE实验表明,速率测定步骤涉及苯甲醇的苄基位置的C–H键断裂(KIE = 2.9)。这种简单的无碱方案可以在温和的条件下以原子经济的方法实现,以中等至极好的收率提供所需的产物。
Carboxamides as ubiquitin-specific protease inhibitors
申请人:Valo Early Discovery, Inc.
公开号:US11524966B1
公开(公告)日:2022-12-13
The present disclosure relates to modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors. The modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25 can be useful in the treatment of cancers, among other ailments.
CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
申请人:Forma Therapeutics, Inc.
公开号:EP3665169A1
公开(公告)日:2020-06-17
[EN] CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS<br/>[FR] CARBOXAMIDES EN TANT QU'INHIBITEURS DE PROTÉASE SPÉCIFIQUES DE L'UBIQUITINE
申请人:FORMA THERAPEUTICS INC
公开号:WO2020033707A1
公开(公告)日:2020-02-13
The present disclosure relates to modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors. The modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25 can be useful in the treatment of cancers, among other ailments.